The BSE Sensex ended 281 points lower [1] during Monday's trading session as several major indices faced downward pressure.

The decline reflects immediate investor volatility in the Indian equity market, impacting heavyweight stocks and overall index stability.

Market data showed the Nifty fell below 24,300 [1] by the close of trade. This downturn was exacerbated by losses in the pharmaceutical and technology sectors, where shares of Infosys and Sun Pharma dropped by as much as three percent [1].

While some previous sessions this year showed significant gains, including a jump of 965 points on July 17 [9] and a rise of 166 points on July 31 [11], Monday's session reversed those trends. The broader market has faced significant instability recently, with reports indicating that ₹2 lakh crore was wiped out from the market [15].

Other movements throughout the summer showed varying results. On July 31, Jio Fin rose four percent [13] and Tata Steel rose two percent [14]. However, those gains did not offset the losses seen during the most recent closing bell.

Trading activity at the National Stock Exchange in Mumbai remained high during the final hour of trade. Market participants monitored the slide of the Nifty, which had previously ended above 24,334 on July 17 [10] and above 24,350 on July 31 [12].

The current volatility follows a period of erratic performance. Earlier this year, some reports indicated the Sensex gained 460 points [5] and the Nifty ended above 17,600 [4], though these figures differ significantly from the levels seen in August.

The BSE Sensex ended 281 points lower during Monday's trading session.

The shift from the gains seen in July to the losses on August 17 suggests a period of correction or increased risk aversion among investors. The significant drop in high-cap stocks like Infosys and Sun Pharma indicates that the downturn is not limited to a single sector but is affecting key pillars of the Indian index.